Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 3/20 | 0.67 |
| ▸ | CTSK | P43235 | 7/20 | 0.58 |
| ▸ | CTSL | P07711 | 6/20 | 0.58 |
| ▸ | CTSB | P07858 | 3/20 | 0.56 |
| ▸ | CTSS | P25774 | 2/20 | 0.56 |
| ▸ | HTRA1 | Q92743 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7846232 | 0.89 | CAPN1 (0.64) | CAPN1CTSKCTSLCTSBCTSS | |
| SCHEMBL6817056 | 0.87 | CTSS (0.51) | CAPN1CTSKCTSLCTSBCTSS | |
| SCHEMBL7855929 | 0.85 | HTRA1 (0.60) | CAPN1CTSKCTSLCTSBCTSS | |
| SCHEMBL7853467 | 0.85 | CAPN1 (0.59) | CAPN1CTSKCTSLCTSBCTSS | |
| SCHEMBL7855985 | 0.85 | CAPN1 (0.61) | CAPN1CTSKCTSLCTSBCTSS | |
| SCHEMBL8014485 | 0.85 | CAPN1 (0.72) | CAPN1CTSKCTSLCTSBCTSS | |
| SCHEMBL7853397 | 0.85 | CTSK (0.58) | CAPN1CTSKCTSLCTSBCTSS | |
| SCHEMBL7857009 | 0.85 | CTSK (0.58) | CAPN1CTSKCTSLCTSBCTSS | |
| SCHEMBL7854489 | 0.84 | CAPN1 (0.58) | CAPN1CTSKCTSLCTSBCTSS | |
| SCHEMBL3356316 | 0.82 | CAPN1 (0.78) | CAPN1CTSKCTSLCTSBCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6534530-B1 | Administering (benzo)thiazole peptidomimetic as viricide; protease inhibitors | AGOURON PHARMACEUTICALS, INC. | 2003-03-18 | — | — | US | disclosed |
| US-6534530-B1 | Administering (benzo)thiazole peptidomimetic as viricide; protease inhibitors | AGOURON PHARMACEUTICALS, INC. | 2003-03-18 | — | — | US | disclosed |